Nifty

:

24834.85

Sensex

:

81332.72

428.75 (1.76%)
1292.92 (1.62%)

Login

Nifty
Sensex

:
:

24834.85
81332.72

428.75 (1.76%)
1292.92 (1.62%)

JB Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

59/99

BSE: 506943 | NSE: JBCHEPHARM

Watchlist

NSE BSE

1742.55

05-Jul-2024

Open
High
Low
Previous Close

1792.90
1799.40
1733.05
1785.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

160211
2801.01
1940.00
1183.80

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

29,268.53
52.96
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

29,530.13
0.65%
10.01

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.91
13.89
15.53

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.72
17.87
4.58

PAT CAGR (%)

10 Years
5 Years
3 Years

20.89
16.20
-2.92

P:E (Median)

8 Years
5 Years
3 Years

21.88
30.53
39.77

P:BV (Average)

8 Years
5 Years
3 Years

4.61
6.04
7.39

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.50
20.11
24.72

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var%
Net Sales 809.20 699.14 15.74% 800.10 728.94 9.76% 836.76 739.96 13.08% 852.58 716.13 19.05%
Expenses 614.15 537.70 14.22% 585.41 559.45 4.64% 601.92 574.17 4.83% 617.75 548.15 12.70%
EBITDA 195.05 161.44 20.82% 214.69 169.49 26.67% 234.84 165.79 41.65% 234.83 167.98 39.80%
EBIDTM 24.10% 23.09% 26.83% 23.25% 28.07% 22.41% 27.54% 23.46%
Other Income 16.10 3.30 387.88% 6.61 3.11 112.54% 6.84 1.72 297.67% 5.13 0.51 905.88%
Interest 8.32 12.26 -32.14% 11.52 8.65 33.18% 9.46 7.60 24.47% 11.21 5.79 93.61%
Depreciation 39.72 30.56 29.97% 33.37 28.04 19.01% 31.50 27.71 13.68% 30.65 25.69 19.31%
PBT 163.11 121.92 33.78% 176.41 135.91 29.80% 200.72 132.20 51.83% 198.10 137.01 44.59%
Tax 37.26 33.25 12.06% 48.49 34.70 39.74% 55.70 34.48 61.54% 53.53 35.72 49.86%
PAT 125.85 88.67 41.93% 127.92 101.21 26.39% 145.02 97.72 48.40% 144.57 101.29 42.73%
PATM 15.55% 12.68% 15.99% 13.88% 17.33% 13.21% 16.96% 14.14%
EPS 8.11 5.71 42.03% 8.24 6.52 26.38% 9.34 6.30 48.25% 9.32 6.53 42.73%

Description Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var%
Net Sales 861.73 762.32 13.04% 844.51 792.71 6.53% 881.74 809.44 8.93% 896.20 784.81 14.19%
Expenses 663.61 598.68 10.85% 621.39 617.94 0.56% 638.20 624.86 2.13% 664.09 612.05 8.50%
EBITDA 198.12 163.64 21.07% 223.12 174.77 27.66% 243.54 184.58 31.94% 232.11 172.76 34.35%
EBIDTM 22.99% 21.47% 26.42% 22.05% 27.62% 22.80% 25.90% 22.01%
Other Income 16.63 4.58 263.10% 7.35 3.13 134.82% 7.66 1.34 471.64% 5.63 0.89 532.58%
Interest 9.41 13.96 -32.59% 12.49 8.30 50.48% 10.37 7.96 30.28% 12.06 5.83 106.86%
Depreciation 40.74 31.80 28.11% 34.03 28.40 19.82% 32.17 28.13 14.36% 31.38 26.08 20.32%
PBT 164.60 122.46 34.41% 183.95 141.20 30.28% 208.66 149.83 39.26% 194.30 141.74 37.08%
Tax 38.44 34.83 10.36% 50.38 35.10 43.53% 58.07 38.75 49.86% 51.98 36.54 42.26%
PAT 126.16 87.63 43.97% 133.57 106.10 25.89% 150.59 111.08 35.57% 142.32 105.20 35.29%
PATM 14.64% 11.50% 15.82% 13.38% 17.08% 13.72% 15.88% 13.40%
EPS 8.13 5.66 43.64% 8.62 6.86 25.66% 9.72 7.18 35.38% 9.19 6.79 35.35%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 3,298.64 2,884.16 2,189.88 1,892.00 1,640.74 1,501.19 1,254.99 1,198.69 1,164.94 1,061.42 956.53 Net Sales Growth 14.37% 31.70% 15.74% 15.31% 9.30% 19.62% 4.70% 2.90% 9.75% 10.97% Cost Of Goods Sold 1,109.08 1,036.73 743.70 625.76 569.14 536.35 484.27 469.32 470.01 322.91 380.72 Gross Profit 2,189.56 1,847.44 1,446.18 1,266.24 1,071.61 964.83 770.72 729.38 694.93 738.51 575.81 GP Margin 66.38% 64.05% 66.04% 66.93% 65.31% 64.27% 61.41% 60.85% 59.65% 69.58% 60.20% Total Expenditure 2,419.23 2,219.47 1,681.15 1,339.66 1,272.50 1,212.75 1,072.79 980.15 939.21 868.48 802.49 Power & Fuel Cost - 91.44 71.36 62.60 61.54 63.29 58.28 54.89 55.28 53.02 46.61 % Of Sales - 3.17% 3.26% 3.31% 3.75% 4.22% 4.64% 4.58% 4.75% 5.00% 4.87% Employee Cost - 499.95 399.06 305.98 293.78 257.98 217.31 187.86 165.96 146.82 131.85 % Of Sales - 17.33% 18.22% 16.17% 17.91% 17.19% 17.32% 15.67% 14.25% 13.83% 13.78% Manufacturing Exp. - 200.49 176.57 134.52 129.40 139.89 130.97 122.68 119.24 223.30 102.28 % Of Sales - 6.95% 8.06% 7.11% 7.89% 9.32% 10.44% 10.23% 10.24% 21.04% 10.69% General & Admin Exp. - 103.42 93.33 54.90 46.11 49.84 49.82 39.08 32.06 29.92 28.78 % Of Sales - 3.59% 4.26% 2.90% 2.81% 3.32% 3.97% 3.26% 2.75% 2.82% 3.01% Selling & Distn. Exp. - 197.12 133.38 99.94 106.58 104.91 59.44 48.83 48.13 47.39 70.48 % Of Sales - 6.83% 6.09% 5.28% 6.50% 6.99% 4.74% 4.07% 4.13% 4.46% 7.37% Miscellaneous Exp. - 90.33 63.76 55.96 65.96 60.48 72.71 57.49 48.54 45.12 70.48 % Of Sales - 3.13% 2.91% 2.96% 4.02% 4.03% 5.79% 4.80% 4.17% 4.25% 4.37% EBITDA 879.41 664.69 508.73 552.34 368.24 288.44 182.20 218.54 225.73 192.94 154.04 EBITDA Margin 26.66% 23.05% 23.23% 29.19% 22.44% 19.21% 14.52% 18.23% 19.38% 18.18% 16.10% Other Income 34.68 8.65 38.80 115.92 49.57 40.23 56.21 49.51 55.68 10.41 37.54 Interest 40.51 34.31 4.95 7.19 3.16 4.57 3.41 5.00 10.29 6.65 5.93 Depreciation 135.24 111.99 71.28 67.36 65.09 54.82 55.95 46.26 40.41 37.60 27.17 PBT 738.34 527.04 471.29 593.71 349.56 269.28 179.04 216.78 230.69 159.10 158.49 Tax 194.98 138.15 110.29 146.62 71.42 87.22 51.04 43.82 51.49 45.52 25.56 Tax Rate 26.41% 26.21% 23.40% 24.70% 21.03% 32.39% 28.51% 20.21% 22.32% 28.61% 27.19% PAT 543.36 388.89 361.00 447.08 268.14 182.06 128.00 172.96 179.20 113.58 68.43 PAT before Minority Interest 543.36 388.89 361.00 447.08 268.14 182.06 128.00 172.96 179.20 113.58 68.43 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 16.47% 13.48% 16.48% 23.63% 16.34% 12.13% 10.20% 14.43% 15.38% 10.70% 7.15% PAT Growth 39.72% 7.73% -19.25% 66.73% 47.28% 42.23% -25.99% -3.48% 57.77% 65.98% EPS 35.01 25.06 23.26 28.81 17.28 11.73 8.25 11.14 11.55 7.32 4.41

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 3,484.18 3,149.28 2,424.24 2,042.52 1,774.73 1,643.20 1,413.77 1,368.32 1,231.58 1,144.21 1,021.86 Net Sales Growth 10.63% 29.91% 18.69% 15.09% 8.00% 16.23% 3.32% 11.10% 7.64% 11.97% Cost Of Goods Sold 1,182.05 1,168.20 842.93 701.50 630.80 596.46 542.41 552.00 491.41 341.40 413.95 Gross Profit 2,302.13 1,981.08 1,581.31 1,341.02 1,143.93 1,046.74 871.35 816.32 740.17 802.81 607.92 GP Margin 66.07% 62.91% 65.23% 65.66% 64.46% 63.70% 61.63% 59.66% 60.10% 70.16% 59.49% Total Expenditure 2,587.29 2,453.53 1,881.63 1,486.35 1,397.15 1,337.36 1,214.64 1,135.93 1,025.55 964.09 873.67 Power & Fuel Cost - 91.54 71.47 62.60 61.54 63.29 58.28 54.89 55.28 53.02 46.61 % Of Sales - 2.91% 2.95% 3.06% 3.47% 3.85% 4.12% 4.01% 4.49% 4.63% 4.56% Employee Cost - 543.45 439.24 340.60 322.92 288.18 251.10 217.34 175.31 159.56 143.67 % Of Sales - 17.26% 18.12% 16.68% 18.20% 17.54% 17.76% 15.88% 14.23% 13.94% 14.06% Manufacturing Exp. - 210.91 194.00 148.68 140.70 150.49 139.83 131.45 119.35 223.53 102.44 % Of Sales - 6.70% 8.00% 7.28% 7.93% 9.16% 9.89% 9.61% 9.69% 19.54% 10.02% General & Admin Exp. - 110.09 100.46 56.35 48.14 52.97 53.96 42.26 34.82 32.46 31.69 % Of Sales - 3.50% 4.14% 2.76% 2.71% 3.22% 3.82% 3.09% 2.83% 2.84% 3.10% Selling & Distn. Exp. - 233.96 161.80 113.22 116.95 113.59 87.44 78.27 72.72 75.13 73.59 % Of Sales - 7.43% 6.67% 5.54% 6.59% 6.91% 6.18% 5.72% 5.90% 6.57% 7.20% Miscellaneous Exp. - 95.38 71.72 63.38 76.11 72.38 81.61 59.72 76.65 79.01 73.59 % Of Sales - 3.03% 2.96% 3.10% 4.29% 4.40% 5.77% 4.36% 6.22% 6.91% 6.04% EBITDA 896.89 695.75 542.61 556.17 377.58 305.84 199.13 232.39 206.03 180.12 148.19 EBITDA Margin 25.74% 22.09% 22.38% 27.23% 21.28% 18.61% 14.09% 16.98% 16.73% 15.74% 14.50% Other Income 37.27 9.94 40.07 116.62 50.90 41.44 55.29 50.16 56.65 10.89 37.70 Interest 44.33 36.05 5.12 7.24 3.26 4.65 3.49 5.37 10.65 6.82 5.93 Depreciation 138.32 114.41 72.66 68.67 66.32 55.64 56.97 47.22 41.22 38.64 28.02 PBT 751.51 555.23 504.90 596.89 358.89 286.99 193.95 229.94 210.82 145.55 151.94 Tax 198.87 145.23 118.86 148.36 76.50 93.02 55.23 45.55 49.58 45.14 25.95 Tax Rate 26.46% 26.16% 23.54% 24.86% 21.93% 32.41% 28.48% 19.81% 23.52% 31.01% 29.68% PAT 552.64 409.84 385.36 447.96 272.04 193.47 138.34 184.06 161.14 100.41 61.50 PAT before Minority Interest 552.64 410.01 386.04 448.52 272.39 193.97 138.72 184.40 161.24 100.41 61.50 Minority Interest 0.00 -0.17 -0.68 -0.56 -0.35 -0.50 -0.38 -0.34 -0.10 0.00 0.00 PAT Margin 15.86% 13.01% 15.90% 21.93% 15.33% 11.77% 9.79% 13.45% 13.08% 8.78% 6.02% PAT Growth 34.79% 6.35% -13.97% 64.67% 40.61% 39.85% -24.84% 14.22% 60.48% 63.27% EPS 35.61 26.41 24.83 28.86 17.53 12.47 8.91 11.86 10.38 6.47 3.96

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 2,442.48 2,103.67 1,806.46 1,445.29 1,484.56 1,453.39 1,387.86 1,222.71 1,016.31 1,047.81 Share Capital 15.48 15.46 15.46 15.46 16.05 16.71 16.96 16.96 16.96 16.95 Total Reserves 2,305.38 2,025.56 1,791.00 1,429.83 1,468.52 1,436.67 1,370.90 1,205.74 999.35 1,030.82 Non-Current Liabilities 993.50 476.54 86.41 73.29 79.08 62.98 41.79 46.07 34.05 32.56 Secured Loans 383.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 0.40 Long Term Provisions 488.47 402.70 12.57 7.39 5.73 9.67 8.88 10.20 12.03 12.19 Current Liabilities 579.28 418.54 645.74 493.55 763.27 711.89 666.97 735.89 398.40 261.56 Trade Payables 221.71 196.24 164.02 151.88 111.33 100.22 79.03 68.61 62.31 51.69 Other Current Liabilities 236.31 77.46 86.45 100.73 87.05 112.90 118.08 119.03 82.60 94.00 Short Term Borrowings 6.71 26.32 26.43 29.49 25.80 28.48 48.86 174.40 104.73 81.28 Short Term Provisions 114.55 118.52 368.83 211.45 539.10 470.29 421.00 373.85 148.76 34.59 Total Liabilities 4,015.26 2,998.75 2,538.61 2,012.13 2,326.91 2,228.26 2,096.62 2,004.67 1,448.76 1,341.93 Net Block 1,821.66 1,203.67 564.60 583.21 552.11 569.91 608.69 369.35 300.87 282.21 Gross Block 2,522.18 1,796.83 1,108.14 1,105.15 1,011.81 979.68 963.76 679.77 571.73 510.94 Accumulated Depreciation 700.52 593.16 543.54 521.95 459.70 409.78 355.07 310.42 270.86 228.74 Non Current Assets 2,545.71 1,796.70 742.49 805.74 804.94 781.26 941.36 891.59 604.38 378.00 Capital Work in Progress 55.15 18.68 25.57 16.17 15.09 17.40 3.76 134.89 55.17 46.32 Non Current Investment 146.75 145.69 145.88 202.42 228.84 182.92 318.81 364.38 230.72 38.86 Long Term Loans & Adv. 507.64 427.63 5.62 3.59 8.31 10.00 9.22 22.63 17.62 10.62 Other Non Current Assets 14.51 1.04 0.82 0.36 0.59 1.03 0.88 0.33 0.00 0.00 Current Assets 1,469.56 1,202.05 1,796.12 1,206.39 1,521.97 1,446.99 1,155.26 1,113.08 844.38 963.93 Current Investments 192.18 0.00 664.97 333.81 360.65 383.77 224.96 247.28 366.78 497.26 Inventories 386.95 349.78 278.91 232.04 208.10 175.81 159.96 133.29 128.47 111.23 Sundry Debtors 523.58 518.05 374.11 344.24 299.85 300.54 265.10 265.67 248.49 248.05 Cash & Bank 55.76 39.67 26.43 11.56 20.77 14.95 7.20 10.71 9.06 10.80 Other Current Assets 311.08 55.77 43.60 18.03 632.60 571.92 498.05 456.13 91.58 96.59 Short Term Loans & Adv. 271.85 238.77 408.10 266.71 600.11 560.72 485.82 453.62 91.20 96.39 Net Current Assets 890.27 783.51 1,150.38 712.84 758.71 735.10 488.29 377.19 445.98 702.37 Total Assets 4,015.27 2,998.75 2,538.61 2,012.13 2,326.91 2,228.25 2,096.62 2,004.67 1,448.76 1,341.93

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 2,480.35 2,134.12 1,809.72 1,435.49 1,480.12 1,441.56 1,363.67 1,183.84 994.87 1,042.81 Share Capital 15.48 15.46 15.46 15.46 16.05 16.71 16.96 16.96 16.96 16.95 Total Reserves 2,343.26 2,056.01 1,794.27 1,420.03 1,464.08 1,424.84 1,346.70 1,166.87 977.91 1,025.82 Non-Current Liabilities 992.03 475.34 72.47 62.72 64.84 45.66 26.98 31.02 32.62 31.93 Secured Loans 383.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 0.40 Long Term Provisions 494.68 410.43 12.57 7.39 5.73 9.67 12.56 10.43 12.03 12.19 Current Liabilities 625.70 455.16 686.57 516.19 781.54 736.50 693.46 797.22 459.75 276.27 Trade Payables 238.65 224.48 186.92 167.97 117.37 110.39 98.98 90.85 77.51 60.75 Other Current Liabilities 240.33 81.31 89.82 102.67 93.10 119.75 122.15 138.73 103.74 98.06 Short Term Borrowings 28.02 26.32 32.64 29.49 25.80 29.29 48.86 193.02 126.88 81.71 Short Term Provisions 118.71 123.06 377.17 216.06 545.27 477.06 423.47 374.61 151.62 35.76 Total Liabilities 4,098.08 3,069.11 2,572.47 2,016.90 2,329.30 2,226.49 2,086.29 2,013.75 1,487.24 1,351.01 Net Block 1,901.01 1,276.99 633.65 651.26 620.93 639.50 679.44 440.22 328.56 310.55 Gross Block 2,607.77 1,876.20 1,182.55 1,177.43 1,084.83 1,053.76 1,038.55 753.75 601.67 540.54 Accumulated Depreciation 706.76 599.21 548.90 526.17 463.89 414.25 359.10 313.53 273.11 229.99 Non Current Assets 2,498.80 1,744.51 678.57 740.83 740.80 717.89 879.15 831.58 586.31 370.37 Capital Work in Progress 55.15 18.68 25.57 16.17 15.09 17.40 3.76 134.89 55.17 46.36 Non Current Investment 13.78 12.72 12.91 69.45 95.88 49.96 185.84 231.42 184.83 2.75 Long Term Loans & Adv. 514.35 435.07 5.62 3.59 8.31 10.15 9.43 22.63 17.74 10.71 Other Non Current Assets 14.51 1.04 0.82 0.36 0.59 0.88 0.67 2.43 0.00 0.00 Current Assets 1,599.29 1,324.61 1,893.89 1,276.08 1,588.51 1,508.59 1,207.14 1,182.16 900.94 980.65 Current Investments 192.18 0.00 664.97 333.81 360.65 383.77 224.96 247.28 366.78 497.26 Inventories 430.48 409.96 347.45 274.67 243.76 213.73 200.17 187.98 150.27 134.40 Sundry Debtors 575.80 555.69 389.02 345.43 308.22 300.73 265.97 272.64 262.35 235.51 Cash & Bank 78.81 58.53 30.85 30.95 36.80 29.92 13.39 12.90 25.19 11.81 Other Current Assets 322.00 57.43 45.95 18.89 639.08 580.44 502.66 461.34 96.35 101.68 Short Term Loans & Adv. 277.09 243.00 415.66 272.33 605.85 567.50 488.30 458.83 95.97 101.48 Net Current Assets 973.58 869.45 1,207.33 759.88 806.97 772.10 513.68 384.94 441.19 704.37 Total Assets 4,098.09 3,069.12 2,572.46 2,016.91 2,329.31 2,226.48 2,086.29 2,013.74 1,487.25 1,351.02

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 628.64 147.10 335.43 271.95 192.63 115.87 177.58 170.87 143.03 -11.65 PBT 527.04 471.29 593.71 339.56 269.28 179.04 216.78 230.69 159.10 93.99 Adjustment 202.82 97.05 -56.41 15.19 26.87 14.73 10.01 -9.63 35.94 14.11 Changes in Working Capital -12.62 -294.12 -61.45 4.34 -42.44 -39.95 -0.30 1.15 -14.04 -93.19 Cash after chg. in Working capital 717.24 274.22 475.85 359.10 253.70 153.82 226.50 222.22 181.00 14.90 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -88.59 -127.12 -140.41 -87.15 -61.08 -37.95 -48.91 -51.34 -37.97 -26.55 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -955.88 4.18 -230.68 23.80 -27.93 -23.97 -42.45 -51.69 -121.72 -138.77 Net Fixed Assets -761.82 -681.80 -12.39 -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 -55.43 Net Investments -193.24 665.16 -274.62 53.26 -22.80 -22.92 67.89 -14.16 -61.38 -102.46 Others -0.82 20.82 56.33 64.96 24.69 28.51 42.52 150.23 9.30 19.12 Cash from Financing Activity 343.41 -137.85 -86.90 -305.48 -155.66 -59.44 -164.84 -97.46 -23.06 12.12 Net Cash Inflow / Outflow 16.17 13.42 17.86 -9.73 9.05 32.45 -29.71 21.72 -1.75 -138.31 Opening Cash & Equivalents 37.69 24.26 6.37 16.11 7.09 -25.36 4.35 -14.50 10.80 149.11 Closing Cash & Equivalent 53.88 37.69 24.26 6.37 16.11 7.09 -25.36 7.23 9.06 10.80

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 625.61 170.13 314.78 275.75 194.33 122.92 201.13 140.41 126.66 -13.98 PBT 555.23 504.90 596.89 348.89 286.99 193.95 229.94 212.23 145.55 87.44 Adjustment 195.78 102.27 -46.17 7.95 23.72 16.91 13.11 -1.40 38.51 20.75 Changes in Working Capital -29.92 -302.42 -94.21 9.70 -51.47 -47.07 5.92 -16.96 -19.52 -93.71 Cash after chg. in Working capital 721.09 304.75 456.50 366.55 259.24 163.79 248.97 193.88 164.53 14.49 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -95.48 -134.62 -141.72 -90.80 -64.91 -40.87 -47.84 -53.47 -37.87 -28.47 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -961.79 2.32 -230.68 23.93 -27.67 -20.68 -45.31 -27.62 -111.89 -142.50 Net Fixed Assets -761.82 -681.80 -12.39 -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 -55.43 Net Investments -193.24 665.16 -274.62 53.26 -22.80 -22.92 67.89 -14.16 -61.38 -102.46 Others -6.73 18.96 56.33 65.09 24.95 31.80 39.66 174.30 19.13 15.39 Cash from Financing Activity 356.54 -138.39 -87.42 -306.05 -155.74 -59.52 -183.84 -99.62 -1.39 12.04 Net Cash Inflow / Outflow 20.36 34.07 -3.31 -6.38 10.92 42.72 -28.02 13.17 13.38 -144.43 Opening Cash & Equivalents 56.54 22.47 25.75 32.14 21.24 -21.47 6.54 -5.46 11.81 156.23 Closing Cash & Equivalent 76.93 56.54 22.47 25.75 32.14 21.24 -21.47 9.42 25.19 11.81

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 149.97 132.05 233.75 187.02 185.02 173.91 163.62 144.15 119.84 123.66 ROA 11.09% 13.04% 19.65% 12.36% 7.99% 5.92% 8.43% 10.38% 8.14% 5.23% ROE 17.83% 18.77% 27.50% 18.30% 12.39% 9.01% 13.25% 16.01% 11.01% 6.65% ROCE 22.02% 24.04% 36.33% 22.96% 18.30% 12.50% 15.65% 19.14% 14.65% 9.09% Fixed Asset Turnover 1.39 1.54 1.71 1.55 1.51 1.29 1.46 1.86 1.99 1.92 Receivable days 63.54 72.64 69.29 71.64 72.99 82.25 80.81 80.55 84.22 83.37 Inventory Days 44.94 51.19 49.29 48.96 46.67 48.83 44.65 41.01 40.66 37.88 Payable days 73.57 88.41 92.13 39.24 32.65 32.75 29.00 27.03 25.03 24.67 Cash Conversion Cycle 34.91 35.42 26.45 81.36 87.01 98.33 96.46 94.52 99.85 96.57 Total Debt/Equity 0.23 0.01 0.01 0.02 0.02 0.02 0.04 0.14 0.10 0.09 Interest Cover 16.36 96.24 83.55 108.34 59.98 53.45 44.35 23.41 24.93 16.84

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 152.42 134.02 234.17 185.75 184.47 172.50 160.77 139.57 117.31 123.07 ROA 11.44% 13.69% 19.55% 12.53% 8.52% 6.43% 8.99% 9.21% 7.08% 4.64% ROE 18.51% 19.89% 27.64% 18.69% 13.28% 9.89% 14.48% 14.80% 9.86% 5.99% ROCE 22.79% 25.48% 36.53% 23.71% 19.59% 13.70% 16.87% 17.72% 13.49% 8.50% Fixed Asset Turnover 1.46 1.63 1.73 1.57 1.54 1.35 1.53 1.82 2.03 1.92 Receivable days 63.16 69.29 65.62 67.22 67.63 73.15 71.84 79.28 78.41 75.30 Inventory Days 46.91 55.55 55.59 53.31 50.81 53.43 51.77 50.12 44.83 42.16 Payable days 72.35 89.07 92.33 38.74 32.21 33.66 32.86 32.45 27.82 26.91 Cash Conversion Cycle 37.72 35.77 28.88 81.79 86.23 92.93 90.75 96.95 95.43 90.54 Total Debt/Equity 0.23 0.01 0.02 0.02 0.02 0.02 0.04 0.16 0.13 0.09 Interest Cover 16.40 99.60 83.43 108.09 62.74 56.54 43.81 20.80 22.33 15.74

Top Investors:

nippon life india trustee ltd-a/c nippon india pharma fund

axis mutual fund trustee limited a/c axis mutual fund a/c axis small cap fund

government pension fund global

kotak emerging equity scheme

invesco india contra fund

canara robeco mutual fund a/c canara robeco small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

JB Chem & Pharma - Quarterly Results
17th May 2024, 18:24 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback